1 |
Intravenous Drugs |
BBB dysfunction ↑ |
TNF-a |
(35) |
2 |
Cocaine, Methamphetamine, Morphine |
Oxidative stress & BBB permeability ↑ |
gp120 neurotoxicity |
(36–39) |
3 |
Morphine |
Expression of Dendric cell markers ↑ |
CD11c, macDC-SIGN, CD83 |
(40) |
4 |
Methamphetamine, N-Methyl-3,4-methylene-dioxyamphetamine (MDMA), cocaine, nicotine |
BBB dysfunction ↑ |
change in expression & conformation of TJ proteins, glial & astrocyte activation, inducing neuroinflammatory pathways |
(41–43) |
5 |
Methamphetamine |
BBB dysfunction ↑ |
Increasing viral load |
(44) |
6 |
Methamphetamine |
BBB dysfunction ↑ |
MMP level ↑ microglial activation, neuronal & synaptic injury |
(45) |
7 |
Cocaine |
BBB leakage ↑ |
Transmigration of leukocytes/monocytes into CNS |
(46) |
8 |
Cocaine |
Monocyte adhesion and trafficking ↑ |
activated leukocyte cell adhesion molecule (ALCAM) |
(47) |
9 |
Cocaine |
Increased permeability of endothelial barrier ↑ |
PDGF (platelet derived growth factor) implication in activating mitogen activated protein kinases & Egr-1 pathways |
(48, 49) |
10 |
Cocaine |
PDGF-B expression |
Notch-1 activation |
(49) |
11 |
Cannabinoid agonists |
Decrease the permeability of BMVECs, prevent downregulation of TJ proteins such as ZO-1, claudin-5 & JAM-1. Inhibit transmigration of human monocytes across BBB & block BBB permeability in vivo |
Inhibition of calcium influx by substance P & CB(2) receptor (CB2R) |
(50–52) |
12 |
Nicotine |
Dysfunction in BMVECs & EPCs (Endothelial Progenitor Cells) |
nicotine+gp120 = increased serum levels of ubiquitin C-terminal hydrolase 1 (UCHL1) |
(53) |
13 |
Nicotine |
BBB integrity disruption |
nicotine + protease inhibitors = oxidative stress in endothelial cells & multiple efflux transporters |
(54) |